What top creators are saying about Butterfly Network, Inc.(BFLY)
Digital health company specializing in handheld, semiconductor-based ultrasound technology.
8 AI-extracted insights from 6 sources — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 4 scored insights about Butterfly Network, Inc..
The Take
Coverage of Butterfly Network (BFLY) was mixed but leaned skeptical: some speakers pointed to its portable ultrasound technology and partnership, while others questioned whether the investment story has substance.
Bull Case
- Portable ultrasound access: Its devices could support wider access to ultrasound, and one participant saw potential in the business. (per The Shkreli Pill, Martin Shkreli)
- Gates Foundation partnership: A speaker cited the partnership alongside the company’s technology as a reason to consider buying. (per Shkreli Planet, Martin Shkreli)
- Trading interest: Participants discussed buying near $6, and one guest considered re-entering after an earlier trade from about $1 to $7. (per Shkreli Planet, Martin Shkreli)
Bear Case
- Investment-case skepticism: Speakers criticized BFLY as promotional or lacking substance, with one advising betting against it. (per Shkreli Planet, Martin Shkreli)
Catalysts & Targets
- One participant considered buying near $6.
- A guest described a prior trade from about $1 to $7.
AI-generated summary. Not investment advice. Learn more.
Top creators covering Butterfly Network, Inc. (BFLY)
The 6 sources with the most insights about Butterfly Network, Inc. on Kazuha.
Latest insights about Butterfly Network, Inc. (BFLY)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Thursday, October 29, 2026
Speakers were divided: one saw potential in wider access to ultrasound, while another dismissed the business as lacking substance.
Tuesday, October 27, 2026
The discussion was mixed to skeptical: one speaker considered buying near $6 and cited a Gates Foundation partnership, while another criticized the investment case as promotional and lacking substance.
Monday, October 26, 2026
One participant cited its portable ultrasound devices, chip licensing, and Gates Foundation partnership and considered buying around $6; another dismissed the company and advised betting against it. Views were sharply divided.
The guest was considering re-entering after previously trading the stock from about $1 to $7, while the speaker questioned the substance of its investment story.
Friday, June 26, 2026
Produces the chips for the handheld ultrasound technology utilized in the AI-medical pivot.
Friday, June 19, 2026
Stock rose significantly on news of AI-integrated medical devices.
Thursday, June 18, 2026
Viewed as a 'jackpot' trade providing essential hardware for MidJourney's AI medical scanners; strong revenue streams from licensing and chip sales.
Partnering with Midjourney Medical to provide underlying technology for next-generation full-body scanners; seen as a liquid public play for AI-driven medical imaging.
Thursday, October 29, 2026
Speakers were divided: one saw potential in wider access to ultrasound, while another dismissed the business as lacking substance.
Tuesday, October 27, 2026
The discussion was mixed to skeptical: one speaker considered buying near $6 and cited a Gates Foundation partnership, while another criticized the investment case as promotional and lacking substance.
Monday, October 26, 2026
One participant cited its portable ultrasound devices, chip licensing, and Gates Foundation partnership and considered buying around $6; another dismissed the company and advised betting against it. Views were sharply divided.
The guest was considering re-entering after previously trading the stock from about $1 to $7, while the speaker questioned the substance of its investment story.
Friday, June 26, 2026
Produces the chips for the handheld ultrasound technology utilized in the AI-medical pivot.
Friday, June 19, 2026
Stock rose significantly on news of AI-integrated medical devices.
Thursday, June 18, 2026
Viewed as a 'jackpot' trade providing essential hardware for MidJourney's AI medical scanners; strong revenue streams from licensing and chip sales.
Partnering with Midjourney Medical to provide underlying technology for next-generation full-body scanners; seen as a liquid public play for AI-driven medical imaging.
Discussed alongside Butterfly Network, Inc. (BFLY)
Other assets that creators frequently mention in the same content as Butterfly Network, Inc..
Frequently asked
Are top creators bullish or bearish on Butterfly Network, Inc. (BFLY) right now?
Mostly bearish. In the last 30 days, 0 insights were bullish, 1 bearish, and 3 neutral about Butterfly Network, Inc. (BFLY) across 6 financial sources indexed on Kazuha.
Which podcasters and creators cover Butterfly Network, Inc. (BFLY) the most?
The most active sources covering Butterfly Network, Inc. (BFLY) on Kazuha are @realmartinshkreli, @notthreadguy, @1000xnetwork, John Coogan & Jordi Hays, @theshkrelipill. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Butterfly Network, Inc. (BFLY) are on Kazuha?
Kazuha has indexed 8 AI-extracted insights about Butterfly Network, Inc. (BFLY) from 6 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Butterfly Network, Inc. (BFLY)?
Creators covering Butterfly Network, Inc. (BFLY) most frequently also discuss BTC, MU, NLST, ZURA, RARE. See the "Discussed alongside" section above for full asset pages.